Miracor Reports Successful Completion of the ‘Prepare PICSO’ Clinical Trial

VIENNA--(BUSINESS WIRE)--Miracor Medical Systems GmbH announced today the successful completion of the pilot study of its PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) System, designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI). (Click here for 5 minute “Corporate Preview” video with PICSO® animation.)

MORE ON THIS TOPIC